MFF
protein-codingmitochondrial fission factor
Gene summary
This is a nuclear gene encoding a protein that functions in mitochondrial and peroxisomal fission. The encoded protein recruits dynamin-1-like protein (DNM1L) to mitochondria. There are multiple pseudogenes for this gene on chromosomes 1, 5, and X. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
- C2orf33
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~32.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0054865
Submitter: ClinGen
*MFF* was first reported in relation to autosomal recessive encephalopathy due to peroxisomal and mitochondrial fission defect in 2012 (Shamseldin et al., PMID: 22499341). At least 5 variants (nonsense and frameshift) have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of case-level and experimental data: 9.5 points. Variants in this gene have been reported in at least 5 probands in 4 publications (PMIDs: 22499341, 30581454, 26783368, 32181496). This gene disease relationship is supported by in vitro functional assays (PMID: 18353969, 22499341, 28108524, 32224193). In summary, there is moderate evidence to support this gene-disease relationship. Although more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was originally evaluated by the Peroxisomal Disorders GCEP on April 15, 2022. It was reevaluated on May 2, 2024. As a result of this reevaluation, the classification did not change.
Inheritance Pattern: AR
Disease ID:MONDO:0014905
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014905
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014905
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between MFF and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of September 21, 2020. The MFF gene encodes mitochondrial fission factor, which plays an important role in mitochondrial fission. Mitochondria are dynamic organelles constantly moving along the cell cytoskeleton and form functional networks in many cells. Mitochondria undergo frequent fusion and fission events, which allow formation of these networks. Defects in MFF lead to abnormal mitochondrial morphology and dynamics. The MFF gene was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2016 (PMID: 26783368). Evidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included five variants identified in four cases in three publications (PMIDs: 26783368, 30581454, 32181496). No segregation data were available. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, expression, and functional alteration in patient cells (PMIDs: 27977873, 25613900, 26783368). In summary, there is moderate evidence to support this gene-disease relationship. While more evidence is needed to establish this relationship definitively, no convincing evidence has emerged that contradicts the gene-disease relationship. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on September 21, 2020 (SOP Version 7).
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MFF variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001277062.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 19 | 19 | ||||
| missense | 80 | 5 | 85 | |||
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 3 | 1 | 1 | 5 | ||
| splice donor/acceptor (+/-2bp) | 2 | 6 | 8 | |||
| Total | 5 | 4 | 87 | 24 | 0 | 120 |
Highest pathogenic variant AF is 0.0030397393
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001263991.1 | 7 | MANE Select | |
| Ensembl | ENSP00000304898.10 | 7 | MANE Select | |
| RefSeq | NP_001263990.1 | 9 | Standard | |
| RefSeq | NP_001263992.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- mitochondrial fission
- release of cytochrome c from mitochondria
- protein targeting to mitochondrion
- mitochondrial fusion
- regulation of mitochondrion organization
Molecular Function
- protein binding
- protein homodimerization activity
Cellular Component
- mitochondrion
- mitochondrial outer membrane
- peroxisome
- synaptic vesicle
- cell junction
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000353339
- Coding exons
- 9
- Length
- 32684
- Individuals with no LoFs
- 125666
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 82
- Defined
- 125748
- p
- 0.000326
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.445 | 187 | 205 | 0.913 | 0.0000121 | 2189 |
| Missense (PolyPhen) | 58 | 68.317 | 0.84898 | 807 | ||
| Synonymous | 0.885 | 61 | 70.5 | 0.866 | 0.00000399 | 694 |
| Loss of Function | 3.02 | 6 | 20.9 | 0.287 | 0.00000132 | 214 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00013 | 0.00012 | rare |
| Latino/Admixed American | 0.00021 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00061 | 0.00060 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00022 | 0.00022 | rare |
| South Asian | 0.0010 | 0.00098 | notable |
| Other | 0.00050 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in mitochondrial and peroxisomal fission. Promotes the recruitment and association of the fission mediator dynamin-related protein 1 (DNM1L) to the mitochondrial surface. May be involved in regulation of synaptic vesicle membrane dynamics by recruitment of DNM1L to clathrin-containing vesicles. {ECO:0000269|PubMed:18353969, ECO:0000269|PubMed:23530241}.;
Recessive Scores
- pRec
- 0.156
Intolerance Scores
- LoFtool
- 0.864
- RVIS EVS
- -0.07
- RVIS percentile EVS
- 48.54
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- K
- Indispensability pred.
- N
- Indispensability score
- 0.0480
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | High | Medium | High |
| Primary Immunodeficiency | High | High | High |
| Cancer | High | High | High |